Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FINESSE: Lucitanib in ER+ metastatic breast cancer
NCT02053636Phase 2Completed
- Sponsor
- Servier
- Start
- Dec 2013
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 2 trial of lucitanib in breast cancer, sponsored by Servier. Started Dec 2013; status: completed.
02
Drugs
lucitanib
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02053636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053636.